ProCE Banner Activity

Optimizing Frontline Therapy in Ovarian Cancer Using PARP Inhibitors: A Video Roundtable

Slideset Download

Download this slideset from an expert roundtable discussion covering the latest insights on PARP inhibitors for frontline maintenance treatment in patients with ovarian cancer.

This educational activity is intended for clinicians practicing medicine outside of the United States.

Released: May 21, 2021

Expiration: May 20, 2022

Share

Faculty

Nicoletta Colombo

Nicoletta Colombo, MD, PhD

Associate Professor of Obsterics and Gynecology
European Institute of Oncology 
University of Milan-Bicocca
Milan, Italy  

Thomas J. Herzog

Thomas J. Herzog, MD

Associate Professor
Division of Gynecology
Washington University
St Louis, Missouri

Ignace Vergote

Ignace Vergote, MD, PhD

Professor Em. of Department of Obstetrics and Gynecologic Oncology
University Hospitals Leuven Belgium

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

This educational activity is supported by an educational grant from

GlaxoSmithKline

Faculty Disclosure

Primary Author

Nicoletta Colombo, MD, PhD

Associate Professor of Obsterics and Gynecology
European Institute of Oncology 
University of Milan-Bicocca
Milan, Italy  

Thomas J. Herzog, MD

Associate Professor
Division of Gynecology
Washington University
St Louis, Missouri

Ignace Vergote, MD, PhD

Professor Em. of Department of Obstetrics and Gynecologic Oncology
University Hospitals Leuven Belgium